Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Author index

Page Path
HOME > Browse > Author index
Search
Sungjin Chung  (Chung S) 1 Article
Role of Peroxisome Proliferator-Activated Receptor α in Diabetic Nephropathy
Sungjin Chung, Cheol Whee Park
Diabetes Metab J. 2011;35(4):327-336.   Published online August 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.4.327
  • 65,535 View
  • 47 Download
  • 17 Crossref
AbstractAbstract PDFPubReader   

With a developing worldwide epidemic of diabetes mellitus, the renal complications associated with diabetes have become a serious health concern. Primary therapy for treating diabetic nephropathy is a multifactorial process. Peroxisome proliferator-activated receptor alpha (PPARα) agonists have been used primarily in clinical practice for the treatment of dyslipidemia and insulin resistance. Given that PPARα expression and regulation of metabolic pathways are involved in oxidative stress, inflammation, blood pressure regulation, and the renin-angiotensin aldosterone system, PPARα likely influences the development and pathogenesis of diabetic nephropathy via indirect effects on glucose and lipid homeostasis and also by direct action on the kidneys. These findings suggest that PPARα may become an important therapeutic target for treating diabetic renal complications.

Citations

Citations to this article as recorded by  
  • Oxidative stress, inflammation, and steatosis elucidate the complex dynamics of HgCl2 induced liver damage in Channa punctata
    Shefalee Singh, Shikha Dwivedi, Adeel Ahmad Khan, Anamika Jain, Shraddha Dwivedi, Kamlesh Kumar Yadav, Indrani Dubey, Abha Trivedi, Sunil P. Trivedi, Manoj Kumar
    Scientific Reports.2024;[Epub]     CrossRef
  • The Proteome of Circulating Large Extracellular Vesicles in Diabetes and Hypertension
    Akram Abolbaghaei, Maddison Turner, Jean-François Thibodeau, Chet E. Holterman, Christopher R. J. Kennedy, Dylan Burger
    International Journal of Molecular Sciences.2023; 24(5): 4930.     CrossRef
  • Metformin mitigates renal dysfunction in obese insulin-resistant rats via activation of the AMPK/PPARα pathway
    Laongdao Thongnak, Nattavadee Pengrattanachot, Sasivimon Promsan, Nichakorn Phengpol, Prempree Sutthasupha, Krit Jaikumkao, Anusorn Lungkaphin
    Archives of Pharmacal Research.2023; 46(5): 408.     CrossRef
  • A comprehensive insight into the molecular and cellular mechanisms of the effects of Propolis on preserving renal function: a systematic review
    Paniz Anvarifard, Maryam Anbari, Alireza Ostadrahimi, Mohammadreza Ardalan, Zohreh Ghoreishi
    Nutrition & Metabolism.2022;[Epub]     CrossRef
  • APX-115, a pan-NADPH oxidase inhibitor, protects development of diabetic nephropathy in podocyte specific NOX5 transgenic mice
    Eun Soo Lee, Hong Min Kim, Sun Hee Lee, Kyung Bong Ha, Yoon Soo Bae, Soo Jin Lee, Sung Hwan Moon, Eun Young Lee, Ji-Hye Lee, Choon Hee Chung
    Free Radical Biology and Medicine.2020; 161: 92.     CrossRef
  • Fenofibrate decreased microalbuminuria in the type 2 diabetes patients with hypertriglyceridemia
    Xiaomeng Sun, Jia Liu, Guang Wang
    Lipids in Health and Disease.2020;[Epub]     CrossRef
  • AMPK allostery: A therapeutic target for the management/treatment of diabetic nephropathy
    Kehinde Sulaimon Ayinde, Olamide Tosin Olaoba, Boyenle Ibrahim, Du Lei, Qian Lu, Xiaoxing Yin, Temitope Isaac Adelusi
    Life Sciences.2020; 261: 118455.     CrossRef
  • Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor
    Ravi Shankar Singh, Dharmendra Kumar Chaudhary, Aradhana Mohan, Praveen Kumar, Chandra Prakash Chaturvedi, Carolyn M. Ecelbarger, Madan M. Godbole, Swasti Tiwari
    Scientific Reports.2016;[Epub]     CrossRef
  • Upregulation of SIRT1-AMPK by thymoquinone in hepatic stellate cells ameliorates liver injury
    Yong Yang, Ting Bai, You-Li Yao, De-Quan Zhang, Yan-Ling Wu, Li-Hua Lian, Ji-Xing Nan
    Toxicology Letters.2016; 262: 80.     CrossRef
  • Peroxisome proliferator-activated receptor α-dependent renoprotection of murine kidney by irbesartan
    Makoto Harada, Yuji Kamijo, Takero Nakajima, Koji Hashimoto, Yosuke Yamada, Hisashi Shimojo, Frank J. Gonzalez, Toshifumi Aoyama
    Clinical Science.2016; 130(21): 1969.     CrossRef
  • Anthocyanin-rich Seoritae extract ameliorates renal lipotoxicity via activation of AMP-activated protein kinase in diabetic mice
    Eun Sil Koh, Ji Hee Lim, Min Young Kim, Sungjin Chung, Seok Joon Shin, Bum Soon Choi, Hye Won Kim, Seong Yeon Hwang, Sae Woong Kim, Cheol Whee Park, Yoon Sik Chang
    Journal of Translational Medicine.2015;[Epub]     CrossRef
  • Diabetic Kidney Disease: From Epidemiology to Clinical Perspectives
    Cheol Whee Park
    Diabetes & Metabolism Journal.2014; 38(4): 252.     CrossRef
  • Peroxisome proliferator-activated receptor agonists in a battle against the aging kidney
    Marijn M. Speeckaert, Céline Vanfraechem, Reinhart Speeckaert, Joris R. Delanghe
    Ageing Research Reviews.2014; 14: 1.     CrossRef
  • Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats
    Pitchai Balakumar, Rajavel Varatharajan, Ying Hui Nyo, Raja Renushia, Devarajan Raaginey, Ann Nah Oh, Shaikh Sohrab Akhtar, Mani Rupeshkumar, Karupiah Sundram, Sokkalingam A. Dhanaraj
    Pharmacological Research.2014; 90: 36.     CrossRef
  • Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy
    Supriya Kadian, Nanjaian Mahadevan, Pitchai Balakumar
    European Journal of Pharmacology.2013; 698(1-3): 388.     CrossRef
  • Age-Associated Molecular Changes in the Kidney in Aged Mice
    Ji Hee Lim, Eun Nim Kim, Min Young Kim, Sungjin Chung, Seok Joon Shin, Hyung Wook Kim, Chul Woo Yang, Yong-Soo Kim, Yoon Sik Chang, Cheol Whee Park, Bum Soon Choi
    Oxidative Medicine and Cellular Longevity.2012; 2012: 1.     CrossRef
  • Epidemiology of Obesity, the Metabolic Syndrome, and Chronic Kidney Disease
    Rikki M. Tanner, Todd M. Brown, Paul Muntner
    Current Hypertension Reports.2012; 14(2): 152.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer